You have 9 free searches left this month | for more free features.

Resistant Metastatic Melanoma

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Tumor Skin, Metastatic Melanoma, Melanoma Trial in Orlando, Louisville (OBX-115)

Active, not recruiting
  • Tumor Skin
  • +2 more
  • OBX-115
  • Orlando, Florida
  • +1 more
Sep 28, 2023

Metastatic Melanoma Trial in Stockholm (Precision Radiation (SBRT))

Recruiting
  • Metastatic Melanoma
  • Precision Radiation (SBRT)
  • Stockholm, Sweden
    Division of Head-Neck, Lung and Skin cancers, Theme Cancer, Karo
Aug 16, 2022

Melanoma Trial (ONCOS-102, Balstilimab)

Not yet recruiting
  • Melanoma
  • ONCOS-102
  • Balstilimab
  • (no location specified)
Oct 24, 2022

Melanoma, Prostate Cancer, Renal Cancer Trial in Providence (Naltrexone)

Terminated
  • Melanoma
  • +2 more
  • Providence, Rhode Island
    Miriam Hospital
Feb 23, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Tumor Trial in Canada,

Active, not recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +20 more
  • Pembrolizumab
  • Ziv-Aflibercept
  • Tampa, Florida
  • +8 more
Jan 3, 2023

Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Australia, United States (TransCon IL-2 ß/?,

Recruiting
  • Advanced Solid Tumor
  • +7 more
  • TransCon IL-2 β/γ
  • +4 more
  • Boston, Massachusetts
  • +7 more
Nov 16, 2022

Metastatic Melanoma, Skin Cancer Trial in Boston (Ipilimumab, Nivolumab, Cryoablation)

Not yet recruiting
  • Metastatic Melanoma
  • Skin Cancer
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Mar 9, 2023

Hydroxychloroquine, BRAF and MEK Inhibitors in Metastatic

Completed
  • Dermatology and Oncology
  • pre-treatment data
  • during study treatment
  • Pierre-Bénite, France
    Centre Hospitalier Lyon Sud
Feb 16, 2021

Advanced Melanoma, Metastatic Melanoma Trial in Saint Louis (Memory-like natural killer cells, Relatilmab, Nivolumab)

Not yet recruiting
  • Advanced Melanoma
  • Metastatic Melanoma
  • Memory-like natural killer cells
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 16, 2022

Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in

Recruiting
  • Advanced Differentiated Thyroid Gland Carcinoma
  • +102 more
  • Cabozantinib S-malate
  • Nivolumab
  • Chicago, Illinois
  • +2 more
Apr 5, 2022

Melanoma Trial (ABP 206, Nivolumab)

Not yet recruiting
  • Melanoma
  • (no location specified)
Sep 20, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Colorectal Carcinoma, Metastatic Malignant Tumor in the Bone Trial in

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +17 more
  • Cryosurgery
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 29, 2021

Metastatic Uveal Melanoma Trial in Tampa (ZIV-Aflibercept, Cemiplimab)

Recruiting
  • Metastatic Uveal Melanoma
  • Tampa, Florida
    Moffitt Cancer Center
Nov 2, 2023

Melanoma Trial (Blood samples, Skin biopsy)

Not yet recruiting
  • Melanoma
  • Blood samples
  • Skin biopsy
  • (no location specified)
Oct 3, 2022

Uveal Melanoma Trial in Pittsburgh (Tebentafusp)

Not yet recruiting
  • Uveal Melanoma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Oct 5, 2023

Ovarian Cancer, Epithelial, Gastric Cancer, GastroEsophageal Junction (GEJ) Cancer Trial in United Kingdom (NX-1607)

Recruiting
  • Ovarian Cancer, Epithelial
  • +14 more
  • Sutton, Surrey, United Kingdom
  • +6 more
Jul 22, 2022

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial (Sipuleucel-T Injection)

Not yet recruiting
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • Sipuleucel-T Injection
  • (no location specified)
Nov 10, 2023

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in United States (Dabrafenib Mesylate, Tazemetostat

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • Metastatic Melanoma
  • Dabrafenib Mesylate
  • +2 more
  • Atlanta, Georgia
  • +6 more
Nov 30, 2022

Metastatic Uveal Melanoma Trial in Grand Rapids (IDE196, Crizotinib, Pembrolizumab)

Recruiting
  • Metastatic Uveal Melanoma
  • Grand Rapids, Michigan
    The Cancer and Hematology Centers
Aug 14, 2023

Uveal Melanoma, Melanoma, Metastatic Uveal Melanoma Trial in Harrison, New York (Lifileucel (LN-144))

Recruiting
  • Uveal Melanoma
  • +3 more
  • Lifileucel (LN-144)
  • Harrison, New York
  • +1 more
Nov 8, 2022

Immunotherapy in Patients With Metastatic Melanoma

Not yet recruiting
  • Metastatic Melanoma
  • data collection
  • (no location specified)
Nov 28, 2022

Healthcare Resource Utilization and Costs in Metastatic Melanoma

Terminated
  • Metastatic Melanoma
    • East Hanover, New Jersey
      Novartis Investigational Site
    Apr 27, 2023

    Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial (MK-5684, Dexamethasone, Fludrocortisone acetate)

    Not yet recruiting
    • Prostatic Neoplasms
    • Metastatic Castration-Resistant Prostate Cancer
    • (no location specified)
    Oct 23, 2023

    Metastatic Melanoma, Head and Neck Squamous Cell Carcinoma Trial in Portland (GB1211, Pembrolizumab, Placebo)

    Not yet recruiting
    • Metastatic Melanoma
    • Head and Neck Squamous Cell Carcinoma
    • Portland, Oregon
      Providence Portland Medical Center
    Jun 19, 2023

    Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in

    Not yet recruiting
    • Clinical Stage III Cutaneous Melanoma AJCC v8
    • +4 more
    • Nashville, Tennessee
      Vanderbilt University/Ingram Cancer Center
    Feb 28, 2023